QNTM Quantum BioPharma Ltd.

P/E --
Forward P/E --
Price/Sales 91.86
Beta 0.362
Div Yield --
Market Cap --

Company Analysis

Latest News

🟒 Quantum BioPharma is trading 5.6% up today in a technical bounce after recent weakness

Quantum BioPharma is trading 5.6% higher at $3.00 in pre-market as the stock stages a technical rebound after several days of selling pressure. β€’ The move...

πŸ”΄ Quantum BioPharma is trading 5.2% down today, extending a multi-day slide

Quantum BioPharma is trading 5.2% down at $2.70 as the stock continues a multi-day decline with no immediate catalyst identified. β€’ The stock has shown...

🟒 Quantum BioPharma is trading 7.6% up today as earlier sell-off stabilizes

Quantum BioPharma is trading at $3.27, up 7.6% in after-hours trading as the stock finds support following a sharp regular-session decline earlier on July 20,...

πŸ”΄ Quantum BioPharma is trading 5.3% down today as speculative pre-market strength fades

Quantum BioPharma is trading 5.3% down at $3.07 as the stock reverses earlier speculative pre-market gains in the absence of fresh fundamental news. β€’ Shares...

🟒 Quantum BioPharma Ltd. is trading 7.65% up in pre-market

QNTM is trading at $3.49, up 7.65% in pre-market.

🟒 Quantum BioPharma is trading 5.5% up today as it rebounds from recent declines

Quantum BioPharma is trading 5.5% up at $3.45 today as it reverses several days of declines in a move that appears to be a technical rebound. β€’ The move comes...

🟒 QNTM is trading 6.3% up today on positive MS imaging study update

QNTM is trading 6.3% up at $3.66 in pre-market action, rebounding from a recent pullback following a significant clinical milestone. β€’ Quantum BioPharma...

🟒 QNTM is trading 5.8% up after recent Lucid-MS clinical progress and a rebound from yesterday’s selloff

QNTM is trading at 5.8% up now at $3.56 after a sharp 7.18% drop on July 1. The stock has been under pressure from recent Lucid-MS / FDA uncertainty, but the...

QNTM's FDA Roadblock Deepens a Selloff β€” Can a $23 Million Biotech Survive the Wait for Its Only Real Drug?

QNTM's FDA Roadblock Deepens a Selloff β€” Can a $23 Million Biotech Survive the Wait for Its Only Real Drug?

Shares of Quantum BioPharma slid another 8% to $3.33 on July 1, extending a punishing five-session decline from $3.91 that has now erased roughly 15% of...

πŸ”΄ QNTM falls 8% as Lucid-MS Phase 2 IND placed on FDA clinical hold

QNTM is trading at $3.33 (8% down) following news that the FDA has placed a clinical hold on the Investigational New Drug (IND) application for its Lucid-MS...

Quantinuum jumps 5%, following $100 target for Apollo quantum system

Quantinuum jumps 5%, following $100 target for Apollo quantum system

Quantinuum (QNTM) shares rose 5% in pre-market trading. This movement occurred on June 29, 2026, following the end of the company's post-IPO quiet...

πŸ”΄ QNTM is trading 5.3% down today on profit-taking after last week's gains

QNTM is trading 5.3% down at $3.60 as profit-taking extends recent volatility following last week's gains. β€’ The decline appears driven by stock-specific...

πŸ”΄ QNTM is trading 5.1% down today following profit-taking after a strong prior session

QNTM is trading 5.1% down at $3.73 as the stock gives back gains from a strong previous session amid ongoing volatility. β€’ The move follows a 5.4% rally in...

🟒 QNTM is trading 5.4% up today after highlighting its patented MS therapy program

QNTM is trading 5.4% up at $4.12 after receiving positive attention for its multiple sclerosis (MS) therapy program. β€’ A June 25, 2026, press release...

🟒 QNTM makes sharp 10.0% jump

QNTM is trading at $4.24, up 10.0% versus the comparison close of $3.85 during regular trading. This is a price-movement alert; no separate company-specific...

🟒 QNTM makes sharp 10.1% jump

QNTM is trading at $4.03, up 10.1% versus the comparison close of $3.66 during regular trading. This is a price-movement alert; no separate company-specific...

πŸ”΄ Quantum BioPharma Ltd. is trading 5.53% down today after FDA clinical hold on Lucid-MS IND application

Quantum BioPharma Ltd. is trading at $3.59 (-5.53%) today as shares face renewed pressure from the FDA clinical hold on its Lucid-MS IND application. β€’ The...

πŸ”΄ Quantum BioPharma Ltd. is trading 7.1% down today extending volatility following recent FDA clinical hold

Quantum BioPharma Ltd. is trading at $3.53 (7.1% down) in pre-market, extending recent volatility. β€’ This downward trend follows the FDA's clinical hold on its...

πŸ”΄ Quantum BioPharma Ltd. is trading 5.5% down today on profit-taking after yesterday's rally

Quantum BioPharma Ltd. is trading at $3.75 (5.5% down) on profit-taking following a significant upside move in the previous session. β€’ The pullback follows a...

🟒 Quantum BioPharma Ltd. makes sharp 11.2% jump

QNTM is trading at $4.05, up 11.2% versus the comparison close of $3.64 during regular trading. This is a price-movement alert; no separate company-specific...